NVTA
Invitae Corp
A genetic testing company that analyzes DNA from saliva or blood samples to help doctors and patients understand hereditary risks — from cancer and heart conditions to neurological and pediatric disorders. It was founded in 2012 as a spin-off of the DNA sequencing firm Complete Genomics, built on the idea that genomic information should be affordable and accessible to everyone. The name 'Invitae' plays on the word 'invite,' reflecting the company's goal of welcoming people into the world of their own genetic information.
CUSIP: 46185L103HealthcareUS3 holders
Total Value
$72.25M
Total Shares
58.58M
Net Share Change
+1.76M
Activity
3 buying
Investor
Value
Shares
Weight
Change
